Tumor cells in the most common pancreatic cancer share nutrients to live and grow. A new discovery by University of California, Irvine biologists and collaborators during a four-year investigation could help lead to better ...
Nov 22, 2022
0
63
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers ...
Nov 18, 2022
0
951
After statins, the next leading class of medications for managing cholesterol are PCSK9 inhibitors. These highly effective agents help the body pull excess cholesterol from the blood, but unlike statins, which are available ...
Nov 17, 2022
0
70
Researchers have demonstrated in mice a new approach for delivering medication across the blood-brain barrier to treat tumors that cause aggressive, lethal brain cancer.
Nov 17, 2022
0
54
Skoltech researchers have created a solution for quick functional checks of optoacoustic microscopes and tomographs. These are diagnostic devices that use harmless laser irradiation and ultrasound waves instead of X-rays ...
Nov 17, 2022
0
34
HSE researchers have found genes characteristic of the most aggressive subtype of clear cell renal carcinoma. Having studied data on tumor samples from 456 patients, Grigory Puzanov, research fellow at the HSE Faculty of ...
Nov 16, 2022
0
94
A significant obstacle to treating brain cancer is not the cancer, but the brain itself.
Nov 11, 2022
0
62
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a new channel of communication through which non-cancerous cells drive the invasion of cancer cells in pancreatic cancer.
Nov 10, 2022
0
116
Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.
Nov 9, 2022
0
31
A new treatment developed at Tel Aviv University may significantly enhance the efficacy of chemotherapy in breast cancer patients, reducing the risk for lung metastasis following chemo from 52% to only 6%. Conducted in an ...
Nov 7, 2022
0
73
